Dr. Jean-Paul Grund, Ph.D., Klinika adiktologie 1. LF UK a VFN v Praze
European Commission, Directorate-General Justice
New Psychoactive Substances (NPS) are becoming a major challenge to public health and drug policies in Europe and have become a high priority in Europe. Recent reports from the EMCDDA, Early Warning Systems and national focal points note sharp rises in availability and consumption of an ever-increasing number of and variation in notably NPS, as well as synthetic opiates, stimulants and non-medical use of prescription drugs. This illustrates the current changing and interweaving drug markets of irregular/recreational and problematic drug use, including risky drug taking patterns, injecting, polydrug use and related (mental) health issues. The reports emphasize health concerns and stress the need to identify effective health policies in the fields of prevention, demand reduction and harm reduction policies as well as adequate health services.
The proposed project will address the priority of ´Developing innovative methodologies to identify and monitor new trends and patterns in the consumption and adverse consequences of – in particular - new psychoactive substances, and the development of targeted approaches in prevention, harm reduction and treatment.´ This project contributes to the development of innovative and effective health promotion interventions regarding emerging NPS use in Europe by bringing together quality research capacity (Charles University in Prague) and a selected group of experienced service providers in the field of health promotion and harm reduction (APDES, FRG, Praksis, Sananim, Carusel and Monar).
Adiktologie 2/2016 Special Issue, https://www.addictology.cz/journal-archive/2016-2/2-2016/